ArticleExploratory research in clinical and social pharmacy2026
Pharmaceutical interventions in self-medication: A descriptive study in community pharmacies.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The main objective of this study is to characterize self-medication Pharmaceutical Interventions (PI) carried out between 2017 and 2025. Methods: A descriptive study was conductive in 201 community pharmacies. Data were collected using GIPAMED notification grid. Results: This study looked at 3366 PIs involving selfmedication. The main reason for requesting drug by the patient or their representative, leading to an PI, was pain (in nearly one-third of cases). The molecules that caused the highest number of PIs were ibuprofen, paracetamol, oxomemazine, pheniramine in combination, and fosfomycin. The main reasons for PIs were "non-compliance with regulations: request for a prescription drug only", "contraindication with the pathophysiological condition," "non-indication with regard to the symptoms," and "need for a medical consultation: limits of pharmacy advice." The dispenser referred the patient for a consultation in 38.1% of cases. The solution proposed by the pharmacist was accepted by the interlocutor in more than 90% of cases. Conclusions: The overall characterization of PIs provided a descriptive basis for identifying the most common types of PIs, the molecules involved, and how they are resolved. This data highlights areas requiring vigilance when dispensing nonprescription drugs. The prospective PI database developed has thus made a significant contribution to primary care research and, more specifically, to community pharmacy research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.